Lincoln Pharmaceuticals Ltd Fundamental

Incorporated in 1979, Lincoln Pharmaceuticals is an Ahmedabad-based branded-generic formulations company with a portfolio of 600+ formulations across 15+ therapeutic areas. It has a strong domestic franchise in cardiac, diabetic, dermatology, gynaecology, ENT and anti-infective segments, along with an expanding export presence across more than 60 countries.

Lincoln opened FY27 strongly, with Q1FY27 consolidated net profit rising 30.9% YoY to ₹36 crore, total income growing 19% to ₹202 crore and EBITDA increasing 32% to ₹52 crore. This builds on FY26 revenue of ₹704 crore and PAT of ₹88 crore, with part of the profit uplift reflecting higher other income.

The company is targeting sustained double-digit growth, supported by its diversified branded-generic portfolio, deeper penetration in high-margin chronic-therapy segments and management's target of reaching ₹1,000 crore revenue within the next three years.

Exports are emerging as a key growth and margin lever, with Lincoln expanding its presence from more than 60 towards 90 countries. TGA Australia and EU-GMP approvals provide access to higher-value regulated markets and support further international expansion.

The company has a near debt-free balance sheet with more than ₹200 crore of cash on hand, providing financial stability and flexibility for suitable...